THI collaboration receives NIDDK funding for IBD research from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - previously they also received NIH funding for their phase 1 study ... I wonder if our IBD results in the coming months will seek funding from organisations such as these or will we go straight for a license deal ?
https://www.texasheart.org/the-texa...harmaceuticals-inc-to-develop-novel-ibd-drug/
The Texas Heart Institute Collaborates with Aviara Pharmaceuticals, Inc. to Develop Novel IBD Drug
HOUSTON (Sept. 26, 2023) — Aviara Pharmaceuticals, Inc., through a research collaboration with The Texas Heart Institute® (THI), recently was awarded a two-year, $1.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to develop a safe and novel drug for inflammatory bowel disease (IBD).
Cell Therapy News/Articles, page-16861
-
- There are more pages in this discussion • 960 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.035(2.94%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $5.248M | 4.461M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 202567 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 39472 | 10 |
View Market Depth
| Last trade - 15.25pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |